Embracing cytoreductive surgery (CRS) for peritoneal malignancies faces diverse challenges worldwide. This review explores the adoption of CRS, crucial in gastrointestinal and gynecological cancers, revealing significant global disparities. High-income countries lead in establishing CRS programs, while barriers in low- and middle-income nations persist. Access to advanced medical facilities, skilled teams, and funding shape this divide, emphasizing the need to address these challenges for more equitable integration of CRS into routine clinical care globally.
Review by Sedighim S, Khan A (…) Senthil M et 5 al. in J Surg Oncol
© 2023 The Authors. Journal of Surgical Oncology published by Wiley Periodicals LLC.